The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $1.8 in the prior trading day, Organigram Global Inc (NASDAQ: OGI) closed at $1.79, down -0.56%. In other words, the price has decreased by -$0.56 from its previous closing price. On the day, 0.51 million shares were traded. OGI stock price reached its highest trading level at $1.82 during the session, while it also had its lowest trading level at $1.77.
Ratios:
Our goal is to gain a better understanding of OGI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.42 and its Current Ratio is at 2.59. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OGI now has a Market Capitalization of 239899680 and an Enterprise Value of 277197792. As of this moment, Organigram’s Price-to-Earnings (P/E) ratio for their current fiscal year is 275.38, and their Forward P/E ratio for the next fiscal year is 493.11. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.50 while its Price-to-Book (P/B) ratio in mrq is 0.85. Its current Enterprise Value per Revenue stands at 1.238 whereas that against EBITDA is -128.69.
Stock Price History:
The Beta on a monthly basis for OGI is 1.46, which has changed by -0.00555557 over the last 52 weeks, in comparison to a change of 0.1675967 over the same period for the S&P500. Over the past 52 weeks, OGI has reached a high of $1.94, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is 14.41%, while the 200-Day Moving Average is calculated to be 29.87%.
Shares Statistics:
The stock has traded on average 747.06K shares per day over the past 3-months and 590630 shares per day over the last 10 days, according to various share statistics. A total of 134.02M shares are outstanding, with a floating share count of 90.67M. Insiders hold about 32.50% of the company’s shares, while institutions hold 6.21% stake in the company. Shares short for OGI as of 1756425600 were 5546174 with a Short Ratio of 7.42, compared to 1753920000 on 5386646.
Earnings Estimates
As of right now, 1.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.02, with high estimates of -$0.02 and low estimates of -$0.02.
Analysts are recommending an EPS of between $0.05 and $0.05 for the fiscal current year, implying an average EPS of $0.05. EPS for the following year is $0.01, with 1.0 analysts recommending between $0.01 and $0.01.
Revenue Estimates
4 analysts predict $73.02M in revenue for the current quarter. It ranges from a high estimate of $74.5M to a low estimate of $71.07M. As of the current estimate, Organigram Global Inc’s year-ago sales were $44.7MFor the next quarter, 4 analysts are estimating revenue of $69.71M. There is a high estimate of $72.8M for the next quarter, whereas the lowest estimate is $67.22M.
A total of 4 analysts have provided revenue estimates for OGI’s current fiscal year. The highest revenue estimate was $253.7M, while the lowest revenue estimate was $250.19M, resulting in an average revenue estimate of $252.13M. In the same quarter a year ago, actual revenue was $159.84MBased on 4 analysts’ estimates, the company’s revenue will be $290.23M in the next fiscal year. The high estimate is $301.4M and the low estimate is $283.85M.
